The RFKjr Attackers? Follow the Money

 You won't be shocked.  AND substack did the homework on the "grassroots" outfit which is pushing, financing, and promoting the attacks on RFKjr.

No, they are not "grassroots."

 Sponsors for the event included:

Eli Lilly and Company - Lilly is known for its clinical depression drugs Prozac, Cymbalta, and its antipsychotic medication Zyprexa. The company's primary revenue drivers are the diabetes drugs Humalog and Trulicity. It is generally considered the most valuable drug company in the world.

Alnylam Pharmaceuticals – Alnylam is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference (RNAi) drugs for genetically defined diseases.

Genentech, Inc. is a biotech company headquartered in San Francisco. It is a subsidiary of Roche. Roche is a Swiss multinational holding company. It is the fifth-largest drug company in the world.

Other speakers at the exclusive Nucleate event included Lotte Knudsen, Head of IDEA (Innovation & Data Experimentation Advancement) and Chief Scientific Advisor at Novo Nordisk. Novo Nordisk is the second-largest pharmaceutical company in the world.

The people and companies behind Nucleate, the group that sponsored the 2025 conference, are all representatives of investment firms and universities involved in the development and fielding of new pharmaceuticals. These people make money, a lot of it, by pushing new drugs on the American people, and they stand to lose a boatload of cash from RFK, Jr. taking things off the vaccine schedule and pursuing an agenda designed to make Americans healthier, not more drug dependent.

The companies in question include:

Atlas Ventures - “We build breakthrough biotechnology companies.”

Venrock – “Venrock consists of two separate investment programs: a traditional venture capital program, focused on early stage investing in healthcare and technology companies; and a later-stage healthcare program, which implements a venture capital-like long-term approach to investment opportunities in small capitalization public companies and late-stage private healthcare companies.”

Polaris Partners – “For more than two decades, we have collaborated with talented biotech and healthcare entrepreneurs as they build transformational companies.”

RA Capital – “We are dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, diagnostics, services, and research tools.”

Links included so you can dig around more if you like.

Grassroots my assroots.